Quellenangaben

Quellenangaben

  1. PCL-K1005-001-11. LEO Pharma - Data on file.
  2. In vitro release test. LEO Pharma - Data on file.
  3. Kleresca® Acne Treatment Instructions for Use.
  4. Nikolis, A. et al. An estension of a multicentre, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol 2017 (In press). 
  5. Endothelial cell study. LEO Pharma - Data on file.
  6. Kleresca® Skin Rejuvenation Instructions for Use.
  7. Antoniou, C. et al. (2016), A multicenter, randomized, split-face clinical trial evaluating the efficacy and safety of chromophore gel-assisted blue light phototherapy for the treatment of acne. Int J Dermatol 2016; 55: 1321 - 1328.
  8. SKR1. LEO Pharma - Data on file.
  9. SKR Safety Report. LEO Pharma - Data on file.
  10. Skin insert study. LEO Pharma - Data on file.
  11. Cho, S.B., et al., Non-ablative 1550-nm erbium-glass and ablative 10 600-nm carbon dioxide fractional lasers for acne scars: a randomized split-face study with blinded response evaluation. J Eur Acad Dermatol Venereol, 2010; 24(8): 921-5.
  12. KL-K1005-P001. LEO Pharma - Data on file.
  13. Ozolins, M., et al., Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet, 2004; 364(9452): 2188-95.
  14. Thielitz, A. and H. Gollnick, Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol, 2008; 9(6): 369-81.
  15. Hamilton, F.L., et al., Laser and other light therapies for the treatment of acne vulgaris: systematic review. Br J Dermatol, 2009; 160(6): 1273-85.
  16. Sakamoto, F.H.; et al. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy? J Am Acad Dermatol, 2010; 63(2): 183-93; quiz 193-4.
  17. James, W.D., Clinical practice. Acne. N Engl J Med, 2005; 352(14): 1463-72.
  18. McManus, P. and I. Iheanacho, Don't use minocycline as first line oral antibiotic in acne. BMJ, 2007; 334(7585): 154.
  19. Limited, R.P. Roaccutane 10mg Soft Capsules summary of product characteristics. 2012  11 August 2015]; Available from: http://www.medicines.org.uk/emc/medicine/1727.
  20. Zheng, W., et al. Evidence-based review of photodynamic therapy in the treatment of acne. Eur J Dermatol, 2014; 24(4): 444-56.
  21. Nikolis, A., et al. A randomized, placebo-controlled, single-blinded, split-faced clinical trial evaluating the efficacy and safety of KLOX-001 gel formulation with KLOX light-emitting diode light on facial rejuvenation. Clin. Cosmet. Investig. Dermatol, 2016; 9: 115 – 125.
  22. Nielsen, M. E., et al. Introducing: photobiomodulation by low energy chromophore-induced fluorescent light. Mechanisms of Photobiomodulation Therapy. In IV, SPIE Photonics West BIOS, San Francisco 28 January – 2 February 2017.
  23. Kwon, H. H. et al. The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br. J. Dermatol, 2013; 168: 1088–94.
  24. Gold, M. H. et al. Clinical efficacy of home-use blue-light therapy for mild-to moderate acne. J. Cosmet. Laser Ther. 2011; 13: 308–14. 
  25. Ash, C., et al. A randomized controlled study for the treatment of acne vulgaris using high-intensity 414 nm solid state diode arrays. J. Cosmet. Laser Ther. 2015;17(4):170-6
  26. DUSA Pharmaceuticals Inc. DUSA Pharmaceuticals reports results from Phase II clinical trial for PDT of moderate to severe acne. (2006). at http://www.marketwired.com/press-release/DUSA-Pharmaceuticals-Reports-Results-from-Phase-II-Clinical-Trial-PDT-Moderate-Severe-578172.htm
  27. Hession, M. T. & Graber, E. M. Atrophic acne scarring: a review of treatment options. J. Clin. Aesthet. Dermatol, 2015; 8: 50–8.
  28. Freitas, L.F. de & Hamblin, M.R. Proposed Mechanisms of photobiomodulation or low level light therapy. 2016; EEE J Sel Top Quantum Electron 22.
Kleresca®verwendet Cookies, um Ihnen ein bestmögliches Online-Erlebnis zu ermöglichen und anonymisierte, zusammengefasste Daten zur Webseitennutzung zu erheben. Wenn Sie auf „Ja, ich stimme zu“ klicken, erklären Sie sich mit der Verwendung von Cookies einverstanden. In unserer Cookie-Richtlinie erläutern wir Ihnen, welche Cookies wir einsetzen, wie diese funktionieren und wie Sie sie deaktivieren können. Weitere Informationen hierzu finden Sie auch in unserer Datenschutzerklärung